Correlation Between Virax Biolabs and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Citius Oncology,, you can compare the effects of market volatilities on Virax Biolabs and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Citius Oncology,.
Diversification Opportunities for Virax Biolabs and Citius Oncology,
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virax and Citius is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Citius Oncology, go up and down completely randomly.
Pair Corralation between Virax Biolabs and Citius Oncology,
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.56 times more return on investment than Citius Oncology,. However, Virax Biolabs is 1.56 times more volatile than Citius Oncology,. It trades about 0.09 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 104.00 in Virax Biolabs Group on September 1, 2024 and sell it today you would earn a total of 93.00 from holding Virax Biolabs Group or generate 89.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 61.9% |
| Values | Daily Returns |
Virax Biolabs Group vs. Citius Oncology,
Performance |
| Timeline |
| Virax Biolabs Group |
| Citius Oncology, |
Virax Biolabs and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Citius Oncology,
The main advantage of trading using opposite Virax Biolabs and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Virax Biolabs vs. Tff Pharmaceuticals | Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. Inhibrx | Virax Biolabs vs. Enliven Therapeutics |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |